Skip to main content
. 2012 Oct 17;3:86. doi: 10.3389/fpsyt.2012.00086

Table 1.

Demographics and clinical measuresa.

Characteristic HC (n = 20)f SZ (n = 20) t2 p-value
Age, years 36.3 ± 11.3 39.0 ± 11.4 0.75 0.46
Gender, F/M 8/12 9/11 0.10 0.75
Ethnicity, AA/Cb 10/10 14/6 0.94 0.33
Parental SESc 6.7 ± 5.1 6.8 ± 5.0 0.07 0.94
RBANSd
Total index 87.2 ± 12.5 73.7 ± 10.2 6.16 0.002
Immediate memory 88.6 ± 15.3 77.5 ± 12.3 6.43 0.03
Visuospatial 79.9 ± 15.7 79.9 ± 15.7 2.31 0.69
Language 95.5 ± 14.4 87.3 ± 13.7 2.95 0.11
Attention 96.4 ± 20.8 82.3 ± 12.9 4.58 0.03
Delayed memory 91.8 ± 8.4 72.5 ± 20.7 5.38 0.001
BPRSe
Total 29.2 ± 6.8
Positive 4.5 ± 2.6
Negative 4.3 ± 2.0

χ2 includes Yate’s correction.

aMean ± SD unless indicated otherwise; SZ, schizophrenia; HC, healthy control.

bAA, African American; C, Caucasian.

cSocioeconomic Status; Ranks determined from Diagnostic Interview for Genetic Studies (1–18 scale); higher rank (lower numerical value) corresponds to higher socioeconomic status; information not available for one SZ.

dRepeatable Battery for the Assessment of Neuropsychological Status; data not available for two SZ and two HC.

eBrief Psychiatric Rating Scale (1–7 scale); positive (conceptual disorganization, hallucinatory behavior, and unusual thought content); negative (emotional withdrawal, motor retardation, and blunted affect); data not available for two SZ.

f18 SZ were treated with second generation antipsychotics and two SZ were not taking antipsychotics.